These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17374144)

  • 21. Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice.
    Blaser MC; Wei K; Adams RLE; Zhou YQ; Caruso LL; Mirzaei Z; Lam AY; Tam RKK; Zhang H; Heximer SP; Henkelman RM; Simmons CA
    Circ Res; 2018 Feb; 122(3):405-416. PubMed ID: 29273600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of C-type natriuretic peptide on craniofacial skeletogenesis.
    Nakao K; Okubo Y; Yasoda A; Koyama N; Osawa K; Isobe Y; Kondo E; Fujii T; Miura M; Nakao K; Bessho K
    J Dent Res; 2013 Jan; 92(1):58-64. PubMed ID: 23114031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptide activation of extracellular regulated kinase 1/2 (ERK1/2) pathway by particulate guanylyl cyclases in GH3 somatolactotropes.
    Jonas KC; Melrose T; Thompson IR; Baxter GF; Lipscomb VJ; Niessen SJ; Lawson C; McArdle CA; Roberson MS; McGonnell IM; Wheeler-Jones CP; Fowkes RC
    Cell Tissue Res; 2017 Sep; 369(3):567-578. PubMed ID: 28451751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.
    Yasoda A; Nakao K
    Endocr J; 2010; 57(8):659-66. PubMed ID: 20567091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP.
    Mericq V; Uyeda JA; Barnes KM; De Luca F; Baron J
    Pediatr Res; 2000 Feb; 47(2):189-93. PubMed ID: 10674345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
    Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
    Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis.
    Bükülmez H; Khan F; Bartels CF; Murakami S; Ortiz-Lopez A; Sattar A; Haqqi TM; Warman ML
    Arthritis Rheumatol; 2014 Jan; 66(1):78-89. PubMed ID: 24449577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
    Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
    Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-natriuretic peptide: an important regulator of cartilage.
    Pejchalova K; Krejci P; Wilcox WR
    Mol Genet Metab; 2007 Nov; 92(3):210-5. PubMed ID: 17681481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.
    Fujii T; Hirota K; Yasoda A; Takizawa A; Morozumi N; Nakamura R; Yotsumoto T; Kondo E; Yamashita Y; Sakane Y; Kanai Y; Ueda Y; Yamauchi I; Yamanaka S; Nakao K; Kuwahara K; Jindo T; Furuya M; Mashimo T; Inagaki N; Serikawa T; Nakao K
    PLoS One; 2018; 13(3):e0194812. PubMed ID: 29566041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
    Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
    J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-type natriuretic peptide in reproduction, pregnancy and fetal development.
    Walther T; Stepan H
    J Endocrinol; 2004 Jan; 180(1):17-22. PubMed ID: 14709140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
    Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
    Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormones and osteoporosis update. Effects of natriuretic peptides on endochondral bone growth].
    Yasoda A; Nakao K
    Clin Calcium; 2009 Jul; 19(7):1003-8. PubMed ID: 19567998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous C-type natriuretic peptide therapy for impaired skeletal growth in a murine model of glucocorticoid treatment.
    Ueda Y; Yasoda A; Hirota K; Yamauchi I; Yamashita T; Kanai Y; Sakane Y; Fujii T; Inagaki N
    Sci Rep; 2019 Jun; 9(1):8547. PubMed ID: 31189976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.
    Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M
    Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
    Yasoda A; Kitamura H; Fujii T; Kondo E; Murao N; Miura M; Kanamoto N; Komatsu Y; Arai H; Nakao K
    Endocrinology; 2009 Jul; 150(7):3138-44. PubMed ID: 19282381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.
    Kanai Y; Yasoda A; Mori KP; Watanabe-Takano H; Nagai-Okatani C; Yamashita Y; Hirota K; Ueda Y; Yamauchi I; Kondo E; Yamanaka S; Sakane Y; Nakao K; Fujii T; Yokoi H; Minamino N; Mukoyama M; Mochizuki N; Inagaki N
    J Clin Invest; 2017 Nov; 127(11):4136-4147. PubMed ID: 28990933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BDNF alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes.
    Hutchison MR
    Mol Endocrinol; 2012 Aug; 26(8):1406-16. PubMed ID: 22700586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
    Tokudome T; Horio T; Soeki T; Mori K; Kishimoto I; Suga S; Yoshihara F; Kawano Y; Kohno M; Kangawa K
    Endocrinology; 2004 May; 145(5):2131-40. PubMed ID: 14749356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.